Regulation of osteoblast differentiation by interleukin-11 via AP-1 and smad signaling

Endocrine Journal

Volumn 59, Issue 2, 2012, Pages 91-101

  Matsumoto, Toshio ^a   Kuriwaka Kido, Rika ^a   Kondo, Takeshi ^a   Endo, Itsuro ^a   Kido, Shinsuke ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Aging; Glucocorticoid; Mechanical stress; Parathyroid hormone; Wnt signaling

Indexed keywords

CALCIUM ION; CYCLIC AMP; CYCLIC AMP BINDING PROTEIN; DICKKOPF 1 PROTEIN; DICKKOPF 2 PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOPROTEIN; INTERLEUKIN 11; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; PROTEIN KINASE C DELTA; SMAD PROTEIN; SMAD1 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR DELTA FOSB; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; WNT PROTEIN;

ADIPOCYTE; AGING; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; COMPLEX FORMATION; DIMERIZATION; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; MECHANICAL STRESS; NONHUMAN; OSTEOBLAST; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY;

ADIPOCYTES; AGING; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTERLEUKIN-11; OSTEOBLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION FACTOR AP-1; WNT SIGNALING PATHWAY;

EID: 84857756547     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0219     Document Type: Review

References (63)

1. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102 (Pt 2): 341-351.
2. Kodama Y, Takeuchi Y, Suzawa M, Fukumoto S, Murayama H, Yamato H, Fujita T, Kurokawa T, Matsumoto T (1998) Reduced expression of interleukin-11 in bone marrow stromal cells of senescence- accelerated mice (SAMP6): relationship to osteopenia with enhanced adipogenesis. J Bone Miner Res 13: 1370-1377.
3. Keller DC, Du XX, Srour EF, Hoffman R, Williams DA (1993) Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 82: 1428-1435.
4. Du X, Williams DA (1997) Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89: 3897-3908.
5. Kawashima I, Ohsumi J, Mita-Honjo K, Shimoda- Takano K, Ishikawa H, Sakakibara S, Miyadai K, Takiguchi Y (1991) Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett 283: 199-202.
6. Girasole G, Passeri G, Jilka RL, Manolagas SC (1994) Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93: 1516-1524.
7. Takeuchi Y, Watanabe S, Ishii G, Takeda S, Nakayama K, Fukumoto S, Kaneta Y, Inoue D, Matsumoto T, Harigaya K, Fujita T (2002) Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem 277: 49011-49018.
8. Tohjima E, Inoue D, Yamamoto N, Kido S, Ito Y, Kato S, Takeuchi Y, Fukumoto S, Matsumoto T (2003) Decreased AP-1 activity and interleukin-11 expression by bone marrow stromal cells may be associated with impaired bone formation in aged mice. J Bone Miner Res 18: 1461-1470.
9. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102: 274-282.
10. Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A, Schmidt- Ullrich R, Ostermay S, Schinke T, Spanbroek R, Zaiss MM, Angel PE, Lerner UH, David IP, Reichardt HM, Amling M, Schutz G, Tuckermann JP (2010) Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 11: 517-531.
11. Jaworski ZF, Liskova-Kiar M, Uhthoff HK (1980) Effect of long-term immobilisation on the pattern of bone loss in older dogs. J Bone Joint Surg Br 62-B: 104-110.
12. Morey ER, Baylink DJ (1978) Inhibition of bone formation during space flight. Science 201: 1138-1141.
13. Kodama Y, Nakayama K, Fuse H, Fukumoto S, Kawahara H, Takahashi H, Kurokawa T, Sekiguchi C, Nakamura T, Matsumoto T (1997) Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats. J Bone Miner Res 12: 1058-1067.
14. Robling AG, Castillo AB, Turner CH (2006) Biomechanical and molecular regulation of bone remodeling. Annu RevBiomedEng 8: 455-498.
15. Hung CT, Allen FD, Pollack SR, Brighton CT (1996) What is the role of the convective current density in the real-time calcium response of cultured bone cells to fluid flow? JBiomech 29: 1403-1409.
16. Pavalko FM, Chen NX, Turner CH, Burr DB, Atkinson S, Hsieh YF, Qiu J, Duncan RL (1998) Fluid shear- induced mechanical signaling in MC3T3-E1 osteoblasts requires cytoskeleton-integrin interactions. Am J Physiol 275: C1591-1601.
17. Burr DB, Robling AG, Turner CH (2002) Effects of biomechanical stress on bones in animals. Bone 30: 781-786.
18. Knothe Tate ML (2003) "Whither flows the fluid in bone?" An osteocyte's perspective. J Biomech 36: 1409-1424.
19. Liu D, Genetos DC, Shao Y, Geist DJ, Li J, Ke HZ, Turner CH, Duncan RL (2008) Activation of extracellular-signal regulated kinase (ERK1/2) by fluid shear is Ca(2+)- and ATP-dependent in MC3T3-E1 osteoblasts. Bone 42: 644-652.
20. You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR (2001) Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem 276: 13365-13371.
21. Kido S, Kuriwaka-Kido R, Imamura T, Ito Y, Inoue D, Matsumoto T (2009) Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation. Bone 45: 1125-1132.
22. Inoue D, Kido S, Matsumoto T (2004) Transcriptional induction of FosB/DeltaFosB gene by mechanical stress in osteoblasts. J Biol Chem 279: 49795-49803.
23. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R (2000) Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6: 985-990.
24. Jochum W, David JP, Elliott C, Wutz A, Plenk H, Jr., Matsuo K, Wagner EF (2000) Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6: 980-984.
25. Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T, Matsushita M, Ito K, Ito Y, Sugimoto Y, Ushikubi F, Ohuchida S, Kondo K, Nakamura T, Narumiya S (2002) Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 99: 4580-4585.
26. Fujino H, Salvi S, Regan JW (2005) Differential regulation of phosphorylation of the cAMP response element- binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. Mol Pharmacol 68: 251-259.
27. Genetos DC, Geist DJ, Liu D, Donahue HJ, Duncan RL (2005) Fluid shear-induced ATP secretion mediates prostaglandin release in MC3T3-E1 osteoblasts. J Bone Miner Res 20: 41-49. 38
28. Nishii N, Nejime N, Yamauchi C, Yanai N, Shinozuka K, Nakabayashi T (2009) Effects of ATP on the intracellular calcium level in the osteoblastic TBR31-2 cell line. BiolPharm Bull 32: 18-23.
29. Fan X, Roy E, Zhu L, Murphy TC, Ackert-Bicknell C, Hart CM, Rosen C, Nanes MS, Rubin J (2004) Nitric 39 oxide regulates receptor activator of nuclear factor-kap-paB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 145: 751-759.
30. Chen P, Jerome CP, Burr DB, Turner CH, Ma YL, Rana Sato M (2007) Interrelationships between bone microarchitecture and strength in ovariectomized mon- 40 keys treated with teriparatide. J Bone Miner Res 22: 841-848.
31. Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF (2006) Teriparatide 41 increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner 42 Res 21: 855-864.
32. Sato M, Westmore M, Ma YL, Schmidt A, Zeng QQ, Glass EV, Vahle J, Brommage R, Jerome CP, Turner CH (2004) Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity. J Bone Miner Res 19: 623-629. 44
33. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish- Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and 45 bone mineral density in postmenopausal women with osteoporosis. NEngl J Med 344: 1434-1441. 46
34. Kaufman JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH (2005) Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and dis- 47 continuation of therapy. Osteoporos Int 16: 510-516.
35. Matsumoto T, Shiraki M, Hagino H, Iinuma H, Nakamura T (2006) Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study. Osteoporos Int 17: 1532-1538.
36. Fujita T, Inoue T, Morii H, Morita R, Norimatsu H, Orimo H, Takahashi HE, Yamamoto K, Fukunaga M (1999) Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose 49 levels. Osteoporos Int 9: 296-306.
37. Kostenuik PJ, Ferrari S, Pierroz D, Bouxsein M, Morony S, Warmington KS, Adamu S, Geng Z, Grisanti M, Shalhoub V, Martin S, Biddlecome G, Shimamoto Boone T, Shen V, Lacey D (2007) Infrequent delivery of a long-acting PTH-Fc fusion protein has potent 50 anabolic effects on cortical and cancellous bone. J Bone Miner Res 22: 1534-1547.
38. O'Brien CA, Plotkin LI, Galli C, Goellner JJ, Gortazar AR, Allen MR, Robling AG, Bouxsein M, Schipani E, Turner CH, Jilka RL, Weinstein RS, Manolagas SC, Bellido T (2008) Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One 3: e2942.
39. Guo J, Liu M, Yang D, Bouxsein ML, Saito H, Galvin RJ, Kuhstoss SA, Thomas CC, Schipani E, Baron R, Bringhurst FR, Kronenberg HM (2010) Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 11: 161-171.
40. Lean JM, Mackay AG, Chow JW, Chambers TJ (1996) Osteocytic expression of mRNA for c-fos and IGF-I: an immediate early gene response to an osteogenic stimulus. Am J Physiol 270: E937-945.
41. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF (1993) Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122: 685-701.
42. Nakabeppu Y, Nathans D (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64: 751-759.
43. Chen J, Kelz MB, Hope BT, Nakabeppu Y, Nestler EJ (1997) Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J Neurosci 17: 4933-4941.
44. Tang W, Yang L, Yang YC, Leng SX, Elias JA (1998) Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1- dependent pathways. J Biol Chem 273: 5506-5513.
45. Urist MR (1965) Bone: formation by autoinduction. Science 150: 893-899.
46. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534.
47. Mitsui N, Suzuki N, Maeno M, Yanagisawa M, Koyama Y, Otsuka K, Shimizu N (2006) Optimal compressive force induces bone formation via increasing bone morphogenetic proteins production and decreasing their antagonists production by Saos-2 cells. Life Sci 78: 2697-2706.
48. Rath B, Nam J, Knobloch TJ, Lannutti JJ, Agarwal S (2008) Compressive forces induce osteogenic gene expression in calvarial osteoblasts. JBiomech 41: 1095-1103.
49. Ikegame M, Ishibashi O, Yoshizawa T, Shimomura J, Komori T, Ozawa H, Kawashima H (2001) Tensile stress induces bone morphogenetic protein 4 in preo- steoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture. J Bone Miner Res 16: 24-32.
50. McCormick SM, Saini V, Yazicioglu Y, Demou ZN, Royston TJ (2006) Interdependence of pulsed ultra-sound and shear stress effects on cell morphology and gene expression. Ann BiomedEng 34: 436-445.
51. Kido S, Kuriwaka-Kido R, Umino-Miyatani Y, Endo I, Inoue D, Taniguchi H, Inoue Y, Imamura T, Matsumoto T (2010) Mechanical Stress Activates Smad Pathway through PKCS to Enhance Interleukin-11 Gene Transcription in Osteoblasts. PLoS ONE 5: e13090.
52. Miyazono K, Maeda S, Imamura T (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 16: 251-263.
53. Baron R, Rawadi G (2007) Targeting the Wnt/beta- catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148: 2635-2643.
54. Moon RT, Bowerman B, Boutros M, Perrimon N (2002) The promise and perils of Wnt signaling through beta- catenin. Science 296: 1644-1646.
55. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S (2000) Arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527-530.
56. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti- Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107: 513-523.
57. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. NEngl JMed 346: 1513-1521.
58. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70: 11-19.
59. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D, Key L, Renton T, Bartels C, Gong Y, Warman ML, De Vernejoul MC, Bollerslev J, Van Hul W (2003) Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72: 763-771.
60. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F (2003) High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960-974.
61. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA, 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157: 303-314.
62. Bennett CN, Longo KA, Wright WS, Suva LJ, Lane TF, Hankenson KD, MacDougald OA (2005) Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 102: 3324-3329.
63. Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH (2008) Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem 283: 5866-5875.1.